Skip to main content

MoneyWorks4Me

Cipla board to consider unaudited financial result

01 Nov 2013 Evaluate

Cipla has informed that a meeting of the Board of Directors of the Company will be held on November 13, 2013, to consider Unaudited Financial Results for quarter and half year ended September 30, 2013 (Q2).

The above information is a part of company’s filings submitted to BSE

Peers
Company Name CMP
Sun Pharma. Inds. 1878.45
Dr. Reddys Labs. 1378.50
Cipla 1397.60
Lupin 1984.00
Zydus Lifesciences 1189.50
View more..